Free Trial
LON:HEMO

Hemogenyx Pharmaceuticals (HEMO) Share Price, News & Analysis

Hemogenyx Pharmaceuticals logo
GBX 179.36 +1.36 (+0.76%)
As of 07/25/2025 12:31 PM Eastern

About Hemogenyx Pharmaceuticals Stock (LON:HEMO)

Key Stats

Today's Range
172
182.50
50-Day Range
129
180
52-Week Range
124
1,200
Volume
18,719 shs
Average Volume
33,238 shs
Market Capitalization
£6.39 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive HEMO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

HEMO Stock News Headlines

Hemogenyx Awarded Grant
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
See More Headlines

HEMO Stock Analysis - Frequently Asked Questions

Hemogenyx Pharmaceuticals' stock was trading at GBX 402 at the start of the year. Since then, HEMO shares have decreased by 55.4% and is now trading at GBX 179.36.

Hemogenyx Pharmaceuticals Plc (LON:HEMO) announced its earnings results on Monday, April, 28th. The company reported ($181.10) EPS for the quarter.

Shares of HEMO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Hemogenyx Pharmaceuticals investors own include 4D pharma (DDDD), genedrive (GDR), International Consolidated Airlines Group (IAG), Active Energy Group (AEG), B&M European Value Retail (BME), BP (BP) and Coats Group (COA).

Company Calendar

Last Earnings
4/28/2025
Today
7/27/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:HEMO
Previous Symbol
LON:SILF
CIK
N/A
Fax
N/A
Employees
14
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (0.20)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£6.89 thousand
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-80.66%
Return on Assets
-37.79%

Debt

Debt-to-Equity Ratio
90.87
Current Ratio
4.38
Quick Ratio
6.72

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
GBX 87.71 per share
Price / Cash Flow
2.05
Book Value
GBX 0.25 per share
Price / Book
728.05

Miscellaneous

Outstanding Shares
3,564,489
Free Float
N/A
Market Cap
£6.39 million
Optionable
Not Optionable
Beta
3.14
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (LON:HEMO) was last updated on 7/27/2025 by MarketBeat.com Staff
From Our Partners